EE9700306A - Helicobacter pylori antigeenid ja vaktsiinisegud - Google Patents

Helicobacter pylori antigeenid ja vaktsiinisegud

Info

Publication number
EE9700306A
EE9700306A EE9700306A EE9700306A EE9700306A EE 9700306 A EE9700306 A EE 9700306A EE 9700306 A EE9700306 A EE 9700306A EE 9700306 A EE9700306 A EE 9700306A EE 9700306 A EE9700306 A EE 9700306A
Authority
EE
Estonia
Prior art keywords
helicobacter pylori
pylori antigens
vaccine mixtures
vaccine
mixtures
Prior art date
Application number
EE9700306A
Other languages
English (en)
Estonian (et)
Inventor
B�lin Ingrid
Svennerholm Ann-Mari
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502007A external-priority patent/SE9502007D0/xx
Priority claimed from SE9601085A external-priority patent/SE9601085D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9700306A publication Critical patent/EE9700306A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EE9700306A 1995-06-01 1996-06-03 Helicobacter pylori antigeenid ja vaktsiinisegud EE9700306A (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502007A SE9502007D0 (sv) 1995-06-01 1995-06-01 Novel polypeptides
SE9601085A SE9601085D0 (sv) 1996-03-21 1996-03-21 Novel polypeptides
PCT/SE1996/000727 WO1996038475A1 (en) 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions

Publications (1)

Publication Number Publication Date
EE9700306A true EE9700306A (xx) 1998-06-15

Family

ID=26662316

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700306A EE9700306A (xx) 1995-06-01 1996-06-03 Helicobacter pylori antigeenid ja vaktsiinisegud

Country Status (22)

Country Link
US (2) US6025164A (xx)
EP (1) EP0828757A1 (xx)
JP (1) JP3380559B2 (xx)
KR (1) KR19990022131A (xx)
CN (1) CN1191544A (xx)
AR (1) AR003125A1 (xx)
BR (1) BR9608627A (xx)
CA (1) CA2222797A1 (xx)
CZ (1) CZ357397A3 (xx)
EE (1) EE9700306A (xx)
HU (1) HUP9901546A3 (xx)
IL (1) IL122340A0 (xx)
IS (1) IS4615A (xx)
MY (1) MY119003A (xx)
NO (1) NO975490L (xx)
NZ (1) NZ303356A (xx)
PL (1) PL323741A1 (xx)
RU (1) RU2195463C2 (xx)
SK (1) SK155297A3 (xx)
TR (1) TR199701471T1 (xx)
TW (1) TW570925B (xx)
WO (1) WO1996038475A1 (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
NZ314585A (en) * 1993-07-27 2000-08-25 Univ New South Wales Method of treating H. Pylori associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
CA2223395A1 (en) * 1995-06-07 1996-12-19 Bjorn L. Mellgard Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
WO1998042372A1 (en) * 1997-03-26 1998-10-01 Avant Immunotherapeutics, Inc. CARBOHYDRATE ANTIGENS WHICH IMMUNOREACT WITH POLYCLONAL ANTISERA AGAINST $i(H. PYLORI)
CA2289253A1 (en) * 1997-04-30 1998-11-05 Merieux Oravax Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
SE9702241D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions IV
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
CA2330313C (en) * 1998-04-30 2012-09-18 Chiron S.P.A. Immunization against and treatment for infection by h.pylori
WO2000049044A1 (en) * 1999-02-19 2000-08-24 Astrazeneca Ab Expression of helicobacter polypeptides in pichia pastoris
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
DE60124526D1 (de) * 2000-04-27 2006-12-28 Max Planck Gesellschaft Methode zur identifizierung von helicobacter antigenen
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
WO2005019249A2 (en) 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7381547B2 (en) * 2004-04-28 2008-06-03 Tzam Diagnostics, Llc Methods and compositions to detect bacteria using multiplex PCR
KR100613924B1 (ko) * 2004-06-23 2006-08-21 현대자동차주식회사 자동차 연료 시스템
WO2007014179A2 (en) * 2005-07-25 2007-02-01 University Of Rochester Method for controlling immunodominance
AU2008279584A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101496898B (zh) * 2009-02-16 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 一种预防和/或治疗幽门螺杆菌感染的疫苗
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
WO2017102779A1 (en) 2015-12-14 2017-06-22 Technische Universität München Helicobacter pylori vaccines
US10577409B2 (en) * 2016-05-26 2020-03-03 Sagabio Co., Ltd. Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody
CN107456578A (zh) * 2016-06-03 2017-12-12 硕英生医股份有限公司 一种关闭病原体的免疫抑制功能的方法及其用途
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
CN113144182B (zh) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 一种幽门螺杆菌口服缓释疫苗及其制备与应用
CN113896775A (zh) * 2021-08-25 2022-01-07 河北医科大学第四医院 幽门螺杆菌特异性免疫原性肽段

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69012318T2 (de) * 1989-03-09 1995-03-09 Praxis Biolog Inc Impfstoffe gegen hämophilus influenzae.
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva

Also Published As

Publication number Publication date
NO975490L (no) 1998-01-07
HUP9901546A3 (en) 2003-07-28
WO1996038475A1 (en) 1996-12-05
PL323741A1 (en) 1998-04-14
EP0828757A1 (en) 1998-03-18
AU6020596A (en) 1996-12-18
MY119003A (en) 2005-03-31
KR19990022131A (ko) 1999-03-25
AU703331B2 (en) 1999-03-25
JP3380559B2 (ja) 2003-02-24
CN1191544A (zh) 1998-08-26
BR9608627A (pt) 1999-06-15
US20020168726A1 (en) 2002-11-14
NZ303356A (en) 1999-05-28
CA2222797A1 (en) 1996-12-05
NO975490D0 (no) 1997-11-28
AR003125A1 (es) 1998-07-08
IS4615A (is) 1997-11-17
IL122340A0 (en) 1998-04-05
JPH11507210A (ja) 1999-06-29
CZ357397A3 (cs) 1998-05-13
SK155297A3 (en) 1998-08-05
TR199701471T1 (xx) 1998-02-21
RU2195463C2 (ru) 2002-12-27
US6025164A (en) 2000-02-15
MX9709194A (es) 1998-07-31
TW570925B (en) 2004-01-11
HUP9901546A2 (hu) 1999-08-30

Similar Documents

Publication Publication Date Title
EE9700306A (xx) Helicobacter pylori antigeenid ja vaktsiinisegud
FI963281A0 (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
RU98100200A (ru) Антигены helicobacter pylori и вакцинные композиции
DK0633946T3 (da) Test for Helicobacter Pylori
EE04481B1 (et) Peptiididel ja adjuvantidel baseeruv farmatseutiline kompositsioon immuunmodulatsiooni jaoks
DE69617211T2 (de) Hepatitis b impfstoff
FI944052A (fi) Oraalinen rokote
EE03778B1 (et) Vähivaktsiin ja selle valmistamismeetod
DE69512853D1 (de) Bilderzeugungsverfahren und -Vorrichtungen
NO965023L (no) Maltitolblanding og fremstilling derav
IS5005A (is) Kjarnsýrur og amínósýruraðir er tengjast Helicobacter pylori og bóluefni úr þeim
EP0821698A4 (en) PROTECTIVE HELIOBACTER ANTIGENES
DK0863991T3 (da) Antigeniske præparater
BR9601193A (pt) Vacina de múltiplos componentes e processos para preparar e administrar a vacina
DK0687728T3 (da) Reovirus stamme 2177 og vaccine indeholdende samme
FI961869A (fi) Rokotteen suunnittelu ja valmistus
NO981407D0 (no) Protein fra Helicobacter pylori
FI974376A0 (fi) Pneumokokkaalisten antigeenien annostelu suun kautta
BR9608827A (pt) Aderências de helicobacter pylori e polipeptídeo codificado do mesmo
FI944314A0 (fi) Vasta-aineen immunogeenisyyden selektiivinen muuttaminen
IS5288A (is) Bóluefnablöndur sem innihalda FlgE pólýpeptíð Helicobacter pylori
IL116541A0 (en) Helicobacter proteins and vaccines
IL116542A0 (en) Helicobacter pylori antigenic protein preparation and immunoassay
ZA955499B (en) Helicobacter proteins and vaccines
GB9413050D0 (en) Helicobacter pylori carbonic anhydrase-like protein